Global
Nasal Spray Market, By Type (Decongestant nasal spray, salt water solution/
saline nasal spray, steroid nasal spray), By Container Design (Pressurized
Canisters, Pump Bottles), By Dosage form (Unit/Single dose, Bi-dose, multi-dose),
By Prescription (Prescribed, Over-the-counter), By Therapeutic Class
(Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), By
Application (Allergic and non-allergic Rhinitis, Nasal Congestion, CNS
disorders, Vaccination, Others), End User (Hospital, ASC/Clinics, Home Care
Setting, Pharmacy, Others), By Geography (North America, Europe, Asia-Pacific,
South America, Middle East & Africa) – Industry Trends and Forecast to 2024
Global Nasal
Spray Market is expected to reach USD 19.4 billion by 2024 from USD 11.9
billion in 2016, at a CAGR of 6.3% in the forecast period 2017 to 2024. The new
market report contains data for historic years 2015, the base year of
calculation is 2016 and the forecast period is 2017 to 2024.
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-nasal-spray-market
Some of the major companies operating
in this market are:
·
Sandoz International,Catalent
·
Pfizer
·
AptarGroup, Inc.
·
Nastech pharmaceutical
·
Adapt Pharma, Inc.
·
Mylan N.V
·
Innovus pharmaceuticals
·
Allergan PLC
·
Nephron pharmaceutical corporation
·
Cipla ltd.
·
Meda pharmaceuticals, Inc.
·
Sunovion pharmaceuticals
·
Teva respiratory, Llc.
·
Apotexcorp
·
Novartis
·
Valent pharmaceuticals international, Inc.
The
global nasal spray market is segmented on the basis of product type, container
design, dosage form, prescription/availability, therapeutic class, application,
and end-user. On the basis of product type the global nasal spray market is
segmented into decongestion nasal spray, salt water solution/ saline nasal
spray, and steroid nasal spray. On the basis of end-user the global nasal spray
market is segmented into hospitals, clinics, home care settings, pharmacies,
and community health care.
Based
on geography the global
nasal spray market is segmented into 5 geographical regions, North America,
Europe, Asia-Pacific, South America and Middle East and Africa. The
geographical regions are further segmented into 24 major countries such as U.S.
Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey,
Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
In 2017, North America is expected to dominate the nasal spray market with
52.1% market share followed by Europe and APAC.
The global nasal spray
market is highly fragmented with various companies operating in local regions.
The major players have used various strategies such as new product launches,
expansions, agreements, joint ventures, partnerships, acquisitions, and others
to increase their footprints in this market. Some of the examples for these
strategies are: In October 2016, Adapt Pharma received Health Canada approval
for its naloxone hydrochloride nasal spray which is used for the treatment of
opioid overdose. The report includes company share data for different
geographies including Global, North America, Europe and APAC.
Read more about the Global Nasal Spray Market
Visit @ http://databridgemarketresearch.com/reports/pharmaceutical/global-nasal-spray-market/
Table
of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL NASAL SPRAY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH
METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL NASAL SPRAY MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL NASAL SPRAY MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET
LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL NASAL SPRAY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. IMPROVING
PATIENT COMPLIANCE AND ACCEPTIBILITY
4.3.1.2.
EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
4.3.2. RESTRAINTS
4.3.2.1. DRUG FAILURES
4.3.2.2. COMPLIANCE OF
INHALING NASAL SPRAYS
4.3.3. OPPURTUNITIES
4.3.3.1. RISING DEMAND
FOR SELF ADMINISTRATIVE DRUG DELIVERY
4.3.3.2. EXPANDING
THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
4.3.4. THREATS
4.3.4.1. PRODUCT
RECALLS
4.3.4.2. REGULATORY
HURDLES
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. NASAL SPRAY
MARKET, BY PRODUCT TYPE
5.1. OVERVIEW
5.2. DECONGESTION NASAL SPRAY
5.3. SALT WATER SOLUTION/ SALINE NASAL SPRAY
5.4. STEROID NASAL SPRAY
6. NASAL SPRAY
MARKET, BY CONTAINER DESIGN
6.1. OVERVIEW
6.2. PRESSURIZED CANISTERS
6.3. PUMP BOTTLES
7. NASAL SPRAY
MARKET, BY DOSAGE FORM
7.1. OVERVIEW
7.2. UNIT/SINGLE DOSE
7.3. BI DOSE
7.4. MULTI DOSE
8. NASAL SPRAY
MARKET, BY PRESCRIPTION/AVAILABILITY
8.1. OVERVIEW
8.2. PRESCRIBED
8.3. OVER THE COUNTER
9. NASAL SPRAY
MARKET, BY THERAPEUTIC CLASS
9.1. OVERVIEW
9.2. ANTIHISTAMINE
9.3. NASAL STEROIDS
9.4. MAST CELL INHIBITOR
9.5. ANTICHOLINERGIC
10. NASAL SPRAY
MARKET, BY APPLICATION
10.1. OVERVIEW
10.2. ALLERGIC AND NON-ALLERGIC RHINITIS
10.3. NASAL CONGESTION
10.4. CENTRAL NERVOUS SYSTEM DISORDERS
10.5. VACCINATION
10.6. OTHERS
11. NASAL SPRAY
MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS
11.3. CLINICS
11.4. HOME CARE SETTINGS
11.5. PHARMACIES
11.6. COMMUNITY HEALTH CARE
12. NASAL SPRAY
MARKET, BY GEOGRAPHY
12.1.
COUNTRYWISE NASAL SPRAY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED
IN THIS CHAPTER BY COUNTRY)
12.1.1. NORTH AMERICA
12.1.1.1. U.S.
12.1.1.2. CANADA
12.1.1.3. MEXICO
12.1.2. EUROPE
12.1.2.1. GERMANY
12.1.2.2. FRANCE
12.1.2.3. U.K.
12.1.2.4. ITALY
12.1.2.5. SPAIN
12.1.2.6. RUSSIA
12.1.2.7. TURKEY
12.1.2.8. BELGIUM
12.1.2.12. NETHERLANDS
12.1.2.13. SWITZERLAND
12.1.2.14. REST OF EUROPE
12.1.3. ASIA-PACIFIC (APAC)
12.1.3.1. JAPAN
12.1.3.2. CHINA
12.1.3.3. SOUTH KOREA
12.1.3.4. INDIA
12.1.3.5. AUSTRALIA
12.1.3.6. SINGAPORE
12.1.3.7. THAILAND
12.1.3.8. MALAYSIA
12.1.3.12. INDONESIA
12.1.3.13. PHILIPPINES
12.1.3.14. REST OF APAC
12.1.4. LATIN AMERICA
12.1.4.1. BRAZIL
12.1.4.2. REST OF LATIN AMERICA
12.1.5. MIDDLE EAST AND AFRICA
12.1.5.1. SOUTH AFRICA
12.1.5.2. REST OF MIDDLE EAST AND AFRICA
12.2. KEY PRIMARY INSIGHTS: BY MAJOR
COUNTRIES
13. NASAL SPRAY
MARKET: COMPETITIVE LANDSCAPE
13.1. GLOBAL NASAL SPRAY MARKET:
COMPANY SHARE ANALYSIS
13.2. U.S. NASAL SPRAY MARKET: COMPANY
SHARE ANALYSIS
13.3. EUROPE NASAL SPRAY MARKET: COMPANY
SHARE ANALYSIS
13.4. APAC NASAL SPRAY MARKET: COMPANY
SHARE ANALYSIS
13.5. SOUTH AMERICA NASAL SPRAY MARKET:
COMPANY SHARE ANALYSIS
13.6. MIDDLE EAST AND AFRICA NASAL SPRAY
MARKET: COMPANY SHARE ANALYSIS
13.7. MERGERS & ACQUISITIONS
13.8. NEW PRODUCT DEVELOPMENT &
APPROVALS
13.9. EXPANSIONS
13.10. REGULATORY CHANGES
13.11. PARTNERSHIP AND OTHER STRATEGIC
DEVELOPMENTS
14. NASAL SPRAY
MARKET, COMPANY PROFILES
14.1. SANDOZ INTERNATIONAL
14.2. CATALENT
14.3. PFIZER, INC.
14.4. PFEIFFER GMBH
14.5. NASTECH PHARMACEUTICAL
14.6. ADAPT PHARMA, INC.
14.7. MYLAN
14.8. INNOVUS PHARMACEUTICALS
14.9. ALLERGAN PLC
14.10. NEPHRON PHARMACEUTICALS CORPORATION
14.11. CIPLA LTD
14.12. MEDA PHARMACEUTICALS, INC.
14.13. SUNOVION PHARMACEUTICALS INC.
14.14. TEVA RESPIRATORY, LLC.
14.15. APOTEX CORP.
15. APPENDIX
15.1. RELATED REPORTS
15.2. CUSTOMIZABLE OPTIONS
15.3. SOURCE SHEET
Inquiry
before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nasal-spray-market
Related
Report
Global
Radiopharmaceuticals Market – Industry Trends and Forecast to 2024
Global
Radiopharmaceuticals Market, By Type (Diagnostic, Therapeutic), Procedural
Volumes (Diagnostic Procedures, Therapeutic Procedures), Application, Sources
(Nuclear Reactors, Cyclotrons), End User, Geography (North America, Europe,
APAC, South America, MEA)– Industry Trends andForecast To 2024
Report Access: http://databridgemarketresearch.com/reports/pharmaceutical/global-radiopharmaceuticals-market-trends-forecast-2024/
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Ankit
Singh
Data
Bridge Market Research
Tel:
+1-888-387-2818